CLINICAL_TRIALS
trial_result
· 2011-07-20
Clinical Trial Update: Pharmacokinetic Study of ARALAST (Human Alpha1- PI) [Phase 1]
Summary
Phase 1 pharmacokinetic study of ARALAST (human Alpha1-antitrypsin) in Alpha 1-Antitrypsin Deficiency was completed with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baxalta now part of Shire | Conditions: Alpha 1-Antitrypsin Deficiency | Phase 1 | Status: COMPLETED | Results posted: 2011-07-20